These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 14656250)

  • 1. Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
    Polkinghorne KR; Zoungas S; Branley P; Villanueva E; McNeil JJ; Atkins RC; McGrath BP; Kerr PG
    Intern Med J; 2003 Nov; 33(11):489-94. PubMed ID: 14656250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men.
    Fenech MF; Dreosti IE; Rinaldi JR
    Carcinogenesis; 1997 Jul; 18(7):1329-36. PubMed ID: 9230275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN; Mamer OA; Hoffer LJ
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
    Hong SY; Yang DH; Chang SK
    Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vitamin B12 on total plasma homocysteine concentration in folate-replete hemodialysis patients.
    Arnadottir M; Hultberg B
    Clin Nephrol; 2003 Mar; 59(3):186-9. PubMed ID: 12653261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults.
    Fenech M; Aitken C; Rinaldi J
    Carcinogenesis; 1998 Jul; 19(7):1163-71. PubMed ID: 9683174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and C-reactive protein levels in haemodialysis patients.
    Koulouridis E; Tzilianos M; Katsarou A; Costimba I; Klonou E; Panagiotaki E; Georgalidis C; Krokida A; Delaportas N; Lachanas A; Karaliotas G; Kaliolia I
    Int Urol Nephrol; 2001; 33(2):207-15. PubMed ID: 12092633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
    Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.